PRTK — Paratek Pharmaceuticals Share News
0.000.00%
HealthcareAdventurousSmall Cap
- $127.83m
- $343.47m
- $160.27m
Brief: Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Responds to Demand Letters From 11 Stockholders Alleging 'Misleading', Incomplete Statements In Proxy Statement Filed On June 30
Brief: Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Announces Second Quarter 2023 Revenue Of $40.0 Million
Paratek Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Paratek Pharmaceuticals Files Definitive Proxy Statement And Letter To Stockholders In Connection With Acquisition By Gurnet Point Capital And Novo Holdings
Paratek Pharmaceuticals Inc expected to post a loss of 31 cents a share - Earnings Preview
Brief: Nexpoint Sends Demand Letter For Books And Records To Paratek Pharmaceuticals In Connection With Proposed Acquisition By Gurnet Point Capital
Brief: Paratek Pharmaceuticals Announces Modification Of Barda Contract To Advance The Development Of Nuzyra® (Omadacycline) For Post-Exposure Prophylaxis (Pep) And Treatment Of Pulmonary Anthrax
Brief: Paratek Pharmaceuticals Acknowledges Receipt Of Nexpoint Letter
Brief: NexPoint Asset Management Sends Open Letter To Board Of Paratek Pharmaceuticals
U.S. RESEARCH ROUNDUP-Integral Ad Science Holding, Paratek Pharmaceuticals, Veru
Paratek Pharma up on buyout deal for nearly $462 mln
Paratek Pharma up on buyout deal for nearly $462 mln
Brief: Paratek Pharmaceuticals To Be Acquired By Gurnet Point Capital And Novo Holdings
Paratek Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Paratek Pharmaceuticals Inc expected to post a loss of 37 cents a share - Earnings Preview
Paratek Pharmaceuticals Inc expected to post a loss of 33 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Booking Holdings, FedEx, LivePerson